THE CORRECTION OF THE CONSEQUENCES OF THE EXPERIMENTAL PROSTATITIS BY NANOPARTICLES OF ORTHOVANADATES OF THE RARE-EARTH ELEMENTS

Authors

  • Chystiakova E. Ye. SI «V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine», Kharkiv, Ukraine
  • Smolienko N. P. SI «V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine», Kharkiv, Ukraine
  • Bielkina I. O. SI «V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine», Kharkiv, UkraineP
  • Velychko N. F. SI «V. Danilevsky Institute for endocrine pathology problems National Academy of Medical sciences of Ukraine», Kharkiv, Ukraine
  • Korenieva Ye. M. SI «V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine», Kharkiv, Ukraine
  • Boiko M. O. SI «V. Danilevsky Institute for Endocrine pathology Problems of the NAMS of Ukraine», Kharkiv, Ukraine
  • Kustova S. P. SI «V. Danilevsky Institute for Endocrine pathology Problems of the NAMS of Ukraine», Kharkiv, Ukraine
  • Klochkov V. K. SI «Institute for Scintillation Materials of NAS of Ukraine", Kharkiv, Ukraine
  • Bondarenko V. O. SI «V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine», Kharkiv, Ukraine
  • Karpenko N. O. SI «V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine», Kharkiv, Ukraine

DOI:

https://doi.org/10.21856/j-PEP.2021.1.13

Keywords:

experimental chronic prostatitis, nanoparticles of silver and rare-earth metals, spermogram, testosterone

Abstract

The management of patients with chronic prostatitis (CP) remains the difficult medical and social problem that makes the elaboration of new prostate protectors actual. The purpose of the work: to ascertain the effectiveness of nanoparticles' of rare-earth elements with different form-factors correction of the pathological seminal's endocrine and spermatogenic function disturbances caused by chronic experimental prostatitis. The modeling of CP in mature rats’ males has been fulfilled using Wartner device by cryo trauma of the prostate gland making. The compositions of nanoparticles (NP) of rare-earth metals (LaVO4 or GdVO4 ) activated by Europium, with NP Ag added, in shape of rods, spheres and grains have been chosen for CP correction. The dose was 0,3 mg/kg of body weight. The drug of comparison was 0,5 % «Prostatilen». The researched substances have been rectally introduced in volume of 0,5 ml from 15th after surgery during next two weeks. The number of leukocytes in blood, condition and masses of the prostate gland and seminal vesicles, the concentration of the general testosterone and spermatogenesis indices have been determined. It has been determined that using of NP composition based on the oxides of rare-earth elements and NP Ag (nanorods) for pathology correction has declined consequences of CP: the general inflammation has been substantially inhibited, mass coefficients of the epididymis and testosterone level have been recovered and spermatogenesis have been improved. For some spermogram indices, the activity of these NP does not concede, but even exceeds the activity of drug of comparison. The using of NP GdVO4:Eu3+ + Ag in the spherical shape has positively influenced the correction of chronic prostatitis, although the effectiveness was less distinct. Thus, the composition of nanoparticles LaVO4:Eu3+ + Ag in the form of rods has a positive effect on the sexual function of rats with chronic prostatitis compared with the effect of nanoparticles GdVO4:Eu3++Ag in the form of spheres or grains.

References

Litvinets EA, Trisch VI. Zdorov’e Muzhchiny 2017; 2(61): 53-57.

Tutchenko OA, Burka VS, Samilyk OV, et al. Reproduktyvna Endokrynologija 2020; 55: 21-28.

Zeynalov OA, Kombarova SP, Bagrov DV, et al. Rev Clin Pharmacol Drug The 2016; 14(4): 42-51. https://doi.org/10.17816/RCF14442-51.

Boles MA, Engel M, Talapin DV. Chem Rev 2016; 116(18): 11220-11289. https://doi.org/10.1021/acs.chemrev.6b00196.

Kinnear C, Moore ThL, Rodriguez-Lorenzo L, et al. Chem Rev 2017; 117(17): 11476-11521. https://doi.org/10.1021/acs.chemrev.7b00194.

Korenyeva YeM, Karpenko NO, Smolyenko NP, et al. Probl Endokryn Patolohiyi 2016; 1: 48-56.

Lu Y, Li Q, Bai D, et al. Int J Nanomedicine 2020; 15: 3415-3431.

Endokrynolohiya 2003; 8(1): 142-145.

Zapadnjuk IP, Zapadnjuk VI, Zaharija EA, et al. Laboratornye zhivotnye. Razvedenie, soderzhanie, ispol'zovanie v jeksperimente, Kiev, 1983: 383 р.

Zaychenko HV, Andriyanenkov OV, Soldatova SO, et al. Informatsiynyy lyst pro novovvedennya v sferi okhorony zdorovya, Kiev, 2013: 28.

Zhukov OB, Evdokimov VV, Bragina ЕЕ. Andrologija I genital’naja hirurgija 2017; 18(1): 3-9. https://doi.org/10.17650/2070-9781-2017-18-102-108.

Men'shikov VV, Delektorskaya LN, Zolotnitskaya RP, et al. Laboratory research methods in clinic: Reference book, Moskva, 1987: 368 р.

Petrishchev VS, Shchelochkov AM. Problemy reproduktsii 2002; 3: 87-91.

Karpenko NO, Talko VV, Omelchuk ST, Lapta SS. Kiev, 2011: 23 р.

Atramentova LO, Utjevs’ka OM. Statystychni metody v biologii’: pidruchnyk, Harkiv, 2007: 288 р.

Brechka NM. Ukr zhurn medytsyny, biolohiyi ta sportu 2019; 4(20): 237-243.

Kavok NS, Averchenko KA, Klochkov VK. Eur Phys J E Soft Matter 2014; 37(12): 127

Al'-Shukri SKH, Gorbachev AG, Knyaz'kin IV, et al. Urologicheskiye vedomosti 2013; 2: 24-30.

Dai L. Department of Environmental, Social and Spatial Change (ENSPAC), Roskilde University, 2013: 153 р.

Black KCL, Wang Y, Luehmann HP, et al. ACS NANO 2014; 8(5): 4385-4394.

Downloads

Published

2021-03-03

How to Cite

Chystiakova, E. Y., Smolienko, N. P., Bielkina, I. O., Velychko, N. F., Korenieva, Y. M., Boiko, M. O., Kustova, S. P., Klochkov, V. K., Bondarenko, V. O., & Karpenko, N. O. (2021). THE CORRECTION OF THE CONSEQUENCES OF THE EXPERIMENTAL PROSTATITIS BY NANOPARTICLES OF ORTHOVANADATES OF THE RARE-EARTH ELEMENTS. Problems of Endocrine Pathology, 75(1), 103-109. https://doi.org/10.21856/j-PEP.2021.1.13

Most read articles by the same author(s)

<< < 1 2